A peptide based on an anti-DNA autoantibody downregulates matrix metalloproteinases in murine models of lupus

Clinical Immunology

Volumn 105, Issue 2, 2002, Pages 223-232

  Faber Elmann, Anat ^a   Eilat, Eran ^a   Zinger, Heidy ^a   Mozes, Edna ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

CDR based peptide; Immunomodulation; Involvement of MMPs in lupus; MMPs in affected kidneys

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; GELATINASE B; MATRIX METALLOPROTEINASE; PEPTIDE ANTIBODY; STROMELYSIN; THREONYLGLYCYLTYROSYLTYROSYLMETHIONYLGLUTAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; BLOOD LEVEL; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; IMMUNOMODULATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE DISTRIBUTION;

EID: 0036867618     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2002.5279     Document Type: Article

References (41)

1. Hahn, B. H., An overview of the pathogenesis of systemic lupus erythematosus. In "Dubois' Lupus Erythematosus" (D. J. Wallace, and B. H. Hahn, Eds.),. 5th ed. Williams and Wilkins; Philadelphia,1993.
2. Theofilopoulos, A. N., and Lawson, B. R., Tumor necrosis factor and other cytokines in murine lupus. Ann. Rheum. Dis. 58(Suppl.), 149-155, 1999.
3. Mendlovic, S., Brocke, S., Shoenfeld, Y., Ben-Bassat, M., Meshorer, A., Bakimer, R., and Mozes, E., Induction of a SLE-like disease in mice by a common human anti-DNA idiotype. Proc. Natl. Acad. Sci. USA 85, 2260-2264, 1988.
4. Waisman, A., Mendelovic, S., Ruiz, J. P., Zinger, H., Meshorer, A., and Mozes, E., The role of the 16/6 idiotype network in the induction and manifestation of systemic lupus erythematosus. Int. Immunol. 5,1293-1300, 1993.
5. Mendlovic, S., Brocke, S., Fricke, H., Shoenfeld, Y., Bakimer, R., and Mozes, E., The genetic regulation of the induction of experimental SLE. Immunology 69, 228-236, 1990.
6. Waisman, A., Ruiz, P. J., Israeli, E., Eilat, E., Konen-Waisman, S., Zinger, H., Dayan, M., and Mozes, E., Modulation of murine systemic lupus erythematosus with peptides based on complementary determining regions of a pathogenic anti-DNA monoclonal antibody. Proc. Natl. Acad. Sci. USA 94, 4620-4625, 1997.
7. Eilat, E., Zinger, H., Nyska, A., and Mozes, E., Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibody. J. Clin. Immunol. 20, 268-278, 2000.
8. Eilat, E., Dayan, M., Zinger, H., and Mozes, E., The mechanism by which a peptide based on the complementarity determining region-1 of a pathogenic anti-DNA autoantibody ameliorates experimental SLE. Proc. Natl. Acad. Sci. USA 98, 1148-1153, 2001.
9. Shingleton, W. D. Hodges, D. J., Brick, P., and Cawston, T. E., Collagenases: A key enzyme in collagen turnover. Biochem. Cell. Biol. 74, 759-775, 1996.
10. Goetzl, E. J., Banda, M. J., and Leppert, D., Matrix metalloproteinases in immunity. J. Immunol. 156, 1-4, 1996.
11. Massova, I., Kotra, L. P., Fridman, R., and Mobashery, S., Matrix metalloproteinases: structures, evolution and diversification. FASEB. J. 12, 1075-1095, 1998.
12. Guedez, L., Lim, M. S., and Stetler-Stevenson, W. G., The role of metalloproteinases and their inhibitors in hematological disorders. Crit. Rev. Oncog. 7, 205-225, 1996.
13. Ozenci, V., Rinaldi, L., Teleshova, N., Matusevicius, D., Kivisak, P., Kouwenhoven, M., and Link, H., Metalloproteinases and their tissue inhibitors in multiple sclerosis. J. Autoimmun. 12, 297-303, 1999.
14. Gijbels, K., Galardy, R. E., and Steinman, L., Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteinases. J. Clin. Invest. 94, 2177-2189, 1994.
15. Keyszer, G., Lambiri, I., Nagel, R., Keysser, C., Keysser, M., Gromnica-Ihle, E., Franz, J., Burmester, G. R., and Jung, K., Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J. Rheumatol. 26, 251-258, 1999.
16. Creange, A., Sharshar,T., Planchenault, T., Christov, C., Poron, F., Raphael, J-C., and Gherardi, R. K., Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barre syndrome. Neurology 53, 1683-1691, 1999.
17. Liu, Z., Shipley, J. M., Vu, T. H., Zhou, X., Diaz, L. A., Werb, Z., and Senior, R. M., Gelatinase B-deficient mice are resistant to experimental bullous Pemphigoid. J. Exp. Med. 188, 475-482, 1998.
18. Hughes, P. M., Wells, G. M. A., Clements, J. M., Gearing, A. J., Redford, E. J., Davies, M., Smith, K. J., Hughes, R. A., Brown, M. C., and Miller, K. M., Matrix metalloproteinase expression during experimental neuritis. Brain 121, 481-494, 1998.
19. Ichikawa, Y., Yamada, C., Horiki, T., Hoshina, Y., and Uchiyama, M., Serum matrix metalloproteinase-3 and fibrin degradation product levels correlate with clinical disease activity in rheumatoid arthritis. Clin. Exp. Rheumatol. 16, 533-540, 1998.
20. Zucker, S., Increased serum stromelysin-1 levels in systemic lupus erythematosus: Lack of correlation with disease activity. J. Rheumatol. 26, 78-80, 1999.
21. Wallace, G. R., Whiston, R. A., Stanford, M. R., Wells, G. M. A., Gearing, A. J. H., and Clements, J. M., The matrix metalloproteinase inhibitor BB-1101 prevents experimental autoimmune uveoretinitis (EAU). Clin. Exp. Immunol. 118, 364-370, 1999.
22. Conway, J. G., Wakefield, J. A., Brown, R. H., Marron, B. E., Sekut, L., Clark, R. L., McGeechan, G. M., and Connolly, K. M., Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. J. Exp. Med. 182, 449-457, 1995.
23. Waisman, A., Shoenfeld, Y., Blank, M., Ruiz, P. J., and Mozes, E., The pathogenic human monoclonal anti-DNA that induces experimental systemic lupus erythematosus in mice is encoded by a VH4 gene segment. Int. Immunol. 7, 689-696, 1995.
24. Shoenfeld, Y., Hsu-Lin, S. C., Gabriels, J. E., Silberstein, L. E., Furie, B. C., Furie, B., Stollar, B. D., and Schwartz, R. S., Production of autoantibodies by human-human hybridomas. J. Clin. Invest. 7, 205-208, 1982.
25. Schnolzer, M., Alewood, P. F., and Kent, S. B. H., In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences. Int. J. Pept. Protein Res. 40, 180-193, 1992.
26. Nakamura, T., Ebihara, I., Osada, S., Takahashi, T., Yamamoto, M., Tomino, Y., and Koide, H., Gene expression of metalloproteinases and their inhibitor in renal tissue of New Zealand Black/White F1 mice. Clin. Sci. 85, 295-301, 1993.
27. Wang, M., Qin, X., Mudgett, J. S., Ferguson, T. A., Senior, R. M., and Welgus, H. G., Matrix metalloproteinase deficiencies affect contact hypersensitivity: Stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc. Natl. Acad. Sci. USA 96, 6885-6889, 1999.
28. Lijnen, H. R., Silence, J., Van Hoef, B., and Collen, D., Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice. Blood 91; 2045-2053, 1998.
29. Ogata, Y., Enghild, J. J., and Nagase, H., Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J. Biol. Chem. 267, 3581-3584, 1992.
30. McMillan, J. I., Riordan, J. W., Couser, W. G., Polock, A. S., and Lovett, D., Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J. Clin. Invest. 97, 1094-1101, 1996.
31. Lovett, D. H., Johnson, R. J., Marti, H. P., Martin, J., Davis, M., and Couser, W. G., Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex mediated glomerulonephritis. Am. J. Pathol. 141, 85-98, 1992.
32. Hawkins, D., and Cochrane, C. G., Glomerular basement membrane in immunologic glomerulonephritis. Immunology 14, 665-681, 1968.
33. Kotajima, L., Aotsuka, S., Fujimani, M., Okawa-Takatsuji, M., Kinoshita, M., Sumiya, M., and Obata, K., Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis. Clin. Exp. Rheum. 16, 409-415, 1998.
34. Gijbels, K., Masure, S., Carton, H., and Opdenakker, G., Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J. Neuroimmunol. 41, 29-34, 1992.
35. Paemen, L., Olsson, T., Soderstrom, M., Van Damme, J., and Opdenakker, G., Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological disease. Eur. J. Neurol.. 1, 55-63, 1994.
36. Miltenburg, A. M., Lacraz, S., Welgus, H. G., and Dayer, J. M., Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts. J. Immunol. 154, 2655-2667, 1995.
37. Chizzolini, C., Rezzonico, R., De Luca, C., Burger, D., and Dayer, J-M., Th2 cell membrane factors in association with IL-4 enhance matrix metalloproteinase-1 (MMP-1) while decreasing MMP-9 production by granulocyte-macrophage colony-stimulating factor-differentiated human monocytes. J. Immunol. 164, 5952-5960, 2000.
38. Dean, G. S., Tyrrell-Price, J., Crawley, E., and Isenberg, D. A., Cytokines and systemic lupus erythematosus. Ann. Rheum. Dis. 59, 243-251, 2000.
39. Segal, R., Bermas, B. L., Dayan, M., Kalush, F., Shearer, G. M., and Mozes, E., Kinetics of cytokine production in experimental systemic lupus erythematosus: Involvement of T helper cell 1/T helper cell 2-type cytokines in disease. J. Immunol. 158, 3009-3016, 1997.
40. Saren, P., Welgus, H. G., and Kovanen, P. T., TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J. Immunol. 157, 4159-4165, 1996.
41. MacNaul, K. L., Chartrain, N., Lark, M., Tocci, M. J., and Hutchinson, N. I., Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinase-1 in rheumatoid synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J. Biol. Chem. 265, 17238-17245, 1990.